R1	Has_value Arg1:T1 Arg2:T2	
*	OR T8 T7 T6 T5 T4 T11
R2	Has_qualifier Arg1:T3 Arg2:T8	
R3	Has_qualifier Arg1:T3 Arg2:T9	
R4	Has_qualifier Arg1:T3 Arg2:T10	
T1	Person 20 24	aged
T2	Value 25 58	=28 days (= 1 month) to <18 years
T3	Procedure 158 177	surgical procedures
T4	Qualifier 135 143	thoracic
T5	Qualifier 125 131	pelvic
T6	Qualifier 108 123	retroperitoneal
T7	Qualifier 97 106	abdominal
T8	Qualifier 88 95	hepatic
T9	Qualifier 83 87	open
T10	Qualifier 70 82	non-emergent
T11	Qualifier 145 156	non-cardiac
T13	Non-query-able 182 344	The first 36 subjects to be enrolled will be subjects aged =1 years to <18 years. ii) The next 4 subjects to be enrolled will be subjects aged =28 days to <1 year
T14	Informed_consent 347 966	The subject's parent/legal guardian must be willing to give permission for the subject to participate in the trial, and provide written informed consent for the subject. In addition, assent must be obtained from paediatric subjects who possess the intellectual and emotional ability to comprehend the concepts involved in the trial. If the paediatric subject is not able to provide assent (due to age, maturity and/or inability to intellectually and/or emotionally comprehend the trial), the parent/legal guardian's written Informed Consent for the subject will be acceptable for the subject to be included in the study
T15	Non-query-able 970 1126	resence of an appropriate mild or moderate bleeding soft tissue or hepatic parenchyma Target Bleeding Site (TBS) identified intra-operatively by the surgeon
T16	Post-eligibility 1129 1211	Ability to firmly press trial treatment at TBS until 4 minutes after randomisation
